Reneo Pharmaceuticals Correlations

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
The current 90-days correlation between Reneo Pharmaceuticals and Cns Pharmaceuticals is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reneo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reneo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Reneo Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Reneo Pharmaceuticals and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Moving together with Reneo Stock

  0.68OPTX Syntec Optics Holdings Buyout TrendPairCorr

Moving against Reneo Stock

  0.57WF Woori Financial GroupPairCorr
  0.54KB KB Financial GroupPairCorr
  0.45TOEYF Toro Energy LimitedPairCorr
  0.39SHG Shinhan FinancialPairCorr
  0.38PPERF Bank Mandiri PerseroPairCorr
  0.38PPERY Bank Mandiri PerseroPairCorr
  0.38PTBRY Bank Negara IndonesiaPairCorr
  0.35PBCRY Bank Central AsiaPairCorr
  0.35PLL Piedmont LithiumPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RPRXOCEA
AVROIMMX
IMMXDNA
OCEAPRME
SMMTCNSP
SMMTOCEA
  
High negative correlations   
AVROPRME
AVROOCEA
IMMXOCEA
IMMXRPRX
AVRORPRX
SMMTAVRO

Risk-Adjusted Indicators

There is a big difference between Reneo Stock performing well and Reneo Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reneo Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PRME  4.00 (0.35) 0.00 (0.13) 0.00 
 7.74 
 25.80 
DNA  4.52  0.35  0.07  0.15  5.92 
 10.46 
 29.19 
OCEA  3.41 (0.55) 0.00 (1.56) 0.00 
 7.46 
 27.01 
RPRX  0.82 (0.14) 0.00 (0.57) 0.00 
 1.38 
 5.23 
IMMX  5.20  0.60  0.10  0.51  5.24 
 17.36 
 35.42 
CNSP  4.37 (0.16) 0.00 (0.19) 0.00 
 10.00 
 39.29 
HEPA  3.82 (0.41) 0.00 (1.37) 0.00 
 8.06 
 35.17 
FRLN  5.90 (0.03) 0.00  0.05  0.00 
 14.23 
 72.38 
AVRO  1.77  0.14  0.05  43.63  1.89 
 4.11 
 14.20 
SMMT  3.86 (0.32) 0.00 (0.38) 0.00 
 7.85 
 24.11 

Delisting Warning - RPHM

Reneo Pharmaceuticals was delisted

The entity Reneo Pharmaceuticals with a symbol RPHM was delisted from NASDAQ Exchange. Please try OnKure Therapeutics, with a symbol OKUR from now on. Check all delisted instruments accross multiple markets.

Reneo Pharmaceuticals Corporate Management

Alejandro MDChief OfficerProfile
Ashley JDChief OfficerProfile
Wendy MBAConsultantProfile
Vineet JindalConsultantProfile
Michael CruseChief OfficerProfile
Jennifer LamPrincipal OfficerProfile

Still Interested in Reneo Pharmaceuticals?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.